Organization | Cantonal Hospital of St. Gallen

Cantonal Hospital of St. Gallen Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: St. Gallen Switzerland (1873)

Organization Overview

First Clinical Trial

1997

NCT00003259

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Aurelius Omlin | Bruno Minotti | Cantonal Hospital of St. Gallen | Cantonal Hospital St.Gallen | Cantonal Hospital St. Gallen | Cantonal Hospital St. Gallen, Department of Surgery | Cantonal Hospital St. Gallen, Dept. of Neurosurgery | Cantonal Hospital St. Gallen, Dept. Oncology | Cantonal Hospital St. Gallen, Switzerland | Cantonal Spital St. Gallen | Daniel Stephan Engeler | Department of General, Visceral, Endocrine and Transplantation Surgery, Cantonal Hospital St. Gallen | Department of Medical Oncology, Cantonal Hospital St. Gallen, Switzerland | Department of Medicine, Kantonsspital St. Gallen, Switzerland | Department of Surgery, Cantonal Hospital St. Gallen | Department of Urology, Cantonal Hospital of St. Gallen | Department of Urology, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland | Deputy Head of the Clinic for Anesthesiology & Intensive Care | Dominik Abt | Georg Kägi, MD | Holger Joswig | Hospital of San Gallen-Switzerland | IKCH - Laboratory St. Gallen Switzerland | Jochen Vehoff | Kantonsspital, CH-9007 St. Gallen | Kantonsspital St. Gallen | Kantonsspital St. Gallen, 9700 St. Gallen - Switzerland | Kantonsspital St. Gallen - Breast Center St. Gallen | Kantonsspital St.Gallen, Clinical Trials Unit, Dermatologie und Venerologie | Kantonsspital St. Gallen CTU | Kantonsspital St. Gallen, Switzerland | Klinik für Psychosomatik und Konsiliarpsychiatrie, Kantonsspital St.Gallen | KSSG | Markus Joerger | Miodrag Filipovic, Prof. Dr. med. | Neurology Department Kantonsspital St. Gallen | Neuromuscular Center/ALS Clinic, Cantonal Hospital St. Gallen, 9007 St. Gallen, Switzerland | Prof. Dr. Silke Gillessen | Rüdiger B. Müller | Sascha Müller | Sibylle Loibl, Prof., MD ASCO, ESGO, ESMO, DKG, DGGG, AGO, DGS, BIG, BCIRG, St. Gallen Faculty Member, SABCS Faculty member | Thomas Steffen | Tumor-und Brustzentrum ZeTuP, St. Gallen, Switzerland | Tumor Zentrum ZeTup St. Gallen und Chur | University of St Gallen | University of St.Gallen

Active Ingredients

Drugs in Phase 4 Trials (16)

abatacept (orencia) (1 trial)

acetaminophen (tylenol) (1 trial)

caffeine (2 trials)

capecitabine (xeloda) (6 trials)

desflurane (suprane) (2 trials)

erlotinib (tarceva) (1 trial)

fingolimod (gilenya) (1 trial)

fluorouracil (efudex) (2 trials)

lopinavir (Kaletra) (1 trial)

midazolam (versed) (1 trial)

morphine (2 trials)

phenprocoumon (liquamar) (1 trial)

propofol (diprivan) (1 trial)

rosuvastatin (crestor) (1 trial)

sunitinib (sutent) (2 trials)

tranexamic acid (cyklokapron) (1 trial)

Drugs in Phase 3 Trials (27)

acetylsalicylic acid (aspirin) (1 trial)

aluminum chlorohydrate (1 trial)

cetuximab (erbitux) (5 trials)

cisplatin (platinol) (7 trials)

denosumab (prolia) (1 trial)

docetaxel (taxotere) (7 trials)

doxorubicin (Doxil) (2 trials)

echinacea (1 trial)

enzalutamide (xtandi) (2 trials)

fentanyl (Innovar) (1 trial)

glycopyrronium (robinul) (1 trial)

inactivated influenza vaccine (1 trial)

indacaterol (arcapta neohaler) (1 trial)

letrozole (femara) (2 trials)

levobupivacaine (chirocaine) (2 trials)

lidocaine (xylocaine) (1 trial)

orteronel (2 trials)

paclitaxel (taxol) (5 trials)

progesterone (progestasert) (1 trial)

radium-223 (xofigo) (1 trial)

ribociclib (kisqali) (1 trial)

rimabotulinumtoxinB (Myobloc) (1 trial)

sodium chloride (1 trial)

sulodexide (Aterina) (1 trial)

tamoxifen (nolvadex) (1 trial)

urea (3 trials)

Drugs in Phase 2 Trials (39)

abiraterone (zytiga) (1 trial)

bendamustine (treanda) (2 trials)

bortezomib (velcade) (2 trials)

capsaicin (qutenza) (1 trial)

carboplatin (paraplatin) (3 trials)

certolizumab pegol (cimzia) (1 trial)

cr1447 (1 trial)

cyclophosphamide (cytoxan) (1 trial)

cyt002-nicqb (1 trial)

darolutamide (Nubeqa) (1 trial)

dendritic cells loaded with prostate cancer (2 trials)

dexamethasone (1 trial)

epirubicin (ellence) (1 trial)

eribulin (halaven) (1 trial)

escitalopram (lexapro) (1 trial)

everolimus (zortress) (2 trials)

gemcitabine (gemzar) (3 trials)

ghrelin (1 trial)

glycerol (1 trial)

ip-001 (2 trials)

l19il2 (1 trial)

l19tnf (1 trial)

lamotrigine (lamictal) (1 trial)

lenalidomide (revlimid) (4 trials)

nelfinavir (viracept) (3 trials)

oxaliplatin (eloxatin) (1 trial)

pertuzumab (perjeta) (1 trial)

pomalidomide (pomalyst) (1 trial)

ribavirin (virazole) (1 trial)

rituximab (rituxan) (2 trials)

sitagliptin (januvia) (2 trials)

sorafenib (nexavar) (1 trial)

temsirolimus (torisel) (1 trial)

tideglusib (1 trial)

trastuzumab (herceptin) (2 trials)

trastuzumab emtansine (kadcyla) (1 trial)

vadimezan (1 trial)

vinorelbine (navelbine) (3 trials)

Drugs in Phase 1 Trials (11)

[18f]-rosma-18-d6 (1 trial)

adch3nsmut1 (1 trial)

azafol (1 trial)

binimetinib (mektovi) (1 trial)

chenodeoxycholic acid (Chenix) (1 trial)

chs-828 (1 trial)

folic acid (1 trial)

mva-nsmut (1 trial)

namitecan (1 trial)

pemetrexed (alimta) (1 trial)

tinostamustine (1 trial)

Drugs in Other Trials (10)

dronabinol (marinol) (1 trial)

human fibrin (Tisseel) (1 trial)

ibuprofen (motrin) (1 trial)

lactobacillus rhamnosus (1 trial)

lamivudine (epivir) (1 trial)

mephamesone (1 trial)

nevirapine (viramune) (1 trial)

triamcinolone (kenalog) (1 trial)

whey protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Adenocarcinoma (Phase 4)

Aortic Dissection (Phase 4)

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Atrial Fibrillation (Phase 4)

Bile Duct Neoplasms (Phase 2)

Biliary Tract Neoplasms (Phase 2)

Breast Neoplasms (Phase 3)

Cachexia (Phase 2)

Cancer Pain (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Basal Cell (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Renal Cell (Phase 4)

Cholangiocarcinoma (Phase 2)

Chronic Disease (Phase 3)

Colonic Neoplasms (Phase 3)

Colorectal Neoplasms (Phase 2)

Communicable Diseases (Phase 3)

Embolism (Phase 4)

Emergencies (Phase 4)

Esophageal Neoplasms (Phase 3)

Gallbladder Neoplasms (Phase 2)

Gastrointestinal Stromal Tumors (Phase 4)

Hand-Foot Syndrome (Phase 3)

Hemorrhage (Phase 4)

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis C (Phase 2)

Hepatitis C, Chronic (Phase 2)

Hepatitis, Chronic (Phase 2)

HIV Infections (Phase 4)

Hypercholesterolemia (Phase 4)

Hyperlipidemia, Familial Combined (Phase 1)

Hyperlipidemias (Phase 1)

Hyperlipoproteinemia Type IV (Phase 1)

Hyperplasia (Phase 3)

Hypertriglyceridemia (Phase 1)

Infections (Phase 3)

Influenza, Human (Phase 3)

Leukemia (Phase 1)

Liver Neoplasms (Phase 2)

Lung Diseases, Obstructive (Phase 3)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Follicular (Phase 2)

Lymphoma, Mantle-Cell (Phase 2)

Melanoma (Phase 2)

Metabolic Syndrome (Phase 1)

Multiple Myeloma (Phase 2)

Multiple Sclerosis (Phase 4)

Multiple Sclerosis, Relapsing-Remitting (Phase 2)

Nausea (Phase 3)

Neoplasm Metastasis (Phase 3)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Neoplastic Cells, Circulating (Phase 4)

Obstetric Labor, Premature (Phase 3)

Pain, Postoperative (Phase 3)

Pancreatic Neoplasms (Phase 4)

Pelvic Pain (Phase 3)

Perinatal Death (Phase 3)

Plasmacytoma (Phase 1)

Premature Birth (Phase 3)

Prostatic Hyperplasia (Phase 3)

Prostatic Neoplasms (Phase 3)

Prostatitis (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Pulmonary Embolism (Phase 4)

Respiratory Tract Infections (Phase 3)

Sarcoma (Phase 2)

Sclerosis (Phase 4)

Skin Neoplasms (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Somatoform Disorders (Phase 3)

Stomach Neoplasms (Phase 3)

Stroke (Phase 2)

Syndrome (Phase 3)

Thyroid Diseases (Phase 3)

Triple Negative Breast Neoplasms (Phase 2)

Vomiting (Phase 3)

Wasting Syndrome (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 99
# of Trial APIs: 103